Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ERN1 | O75460 | 1/20 | 0.65 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.59 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.59 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.59 |
| ▸ | BACE1 | P56817 | 2/20 | 0.52 |
| ▸ | TYR | P14679 | 2/20 | 0.50 |
| ▸ | MAPT | P10636 | 2/20 | 0.50 |
| ▸ | APP | P05067 | 1/20 | 0.50 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.50 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.50 |
| ▸ | NPC1 | O15118 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 2/20 | 0.49 |
| ▸ | POLB | P06746 | 1/20 | 0.49 |
| ▸ | ABL1 | P00519 | 1/20 | 0.49 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.49 |
| ▸ | BCR | P11274 | 1/20 | 0.49 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.49 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.49 |
| ▸ | NQO2 | P16083 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29763600 | 1.00 | ERN1 (0.65) | ERN1GABRA3GABRA2GABRB2BACE1 | |
| SCHEMBL7988050 | 1.00 | ERN1 (0.65) | ERN1GABRA3GABRA2GABRB2BACE1 | |
| SCHEMBL13802132 | 0.85 | CYP1A1 (0.67) | ERN1BACE1TYRMAPTAPP | |
| SCHEMBL9283046 | 0.80 | MAPT (0.44) | ERN1GABRA3GABRA2GABRB2BACE1 | |
| SCHEMBL7991883 | 0.80 | ERN1 (0.59) | ERN1GABRA3GABRA2GABRB2BACE1 | |
| SCHEMBL11971396 | 0.80 | GABRA3 (0.72) | ERN1GABRA3GABRA2GABRB2BACE1 | |
| SCHEMBL11971397 | 0.80 | GABRA3 (0.72) | ERN1GABRA3GABRA2GABRB2BACE1 | |
| SCHEMBL31074926 | 0.80 | ERN1 (0.69) | ERN1GABRA3GABRA2GABRB2BACE1 | |
| SCHEMBL31074932 | 0.80 | ERN1 (0.69) | ERN1GABRA3GABRA2GABRB2BACE1 | |
| SCHEMBL7991886 | 0.80 | ERN1 (0.59) | ERN1GABRA3GABRA2GABRB2BACE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260002924-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2026-01-01 | — | — | US | claimed |
| EP-4477693-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | Korea Research Institute of Chemical Technology (KR) | 2024-12-18 | — | — | EP | claimed |
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2023195794-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | 한국화학연구원 | 2023-10-12 | — | — | WO | claimed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| EP-4737508-A1 | CHEMICAL RECYCLING METHOD FOR MIXED WASTE POLYMERS | Korea Research Institute of Chemical Technology (KR) | 2026-05-06 | — | — | EP | disclosed |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260002924-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) | 2026-01-01 | — | — | US | disclosed |
| EP-4593631-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | Mars, Incorporated (US) | 2025-08-06 | — | — | EP | disclosed |
| US-20250161394-A1 | Compositions Comprising Kavalactones | NATURAL EXTRACTION SYS LLC (US) | 2025-05-22 | — | — | US | disclosed |
| CN-119968127-A | Animal food compositions with improved palatability and customizable properties and methods of making the same | 玛氏公司 | 2025-05-09 | — | — | CN | disclosed |
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2023-03-23 | — | — | US | disclosed |
| WO-2022182523-A1 | COMPOSITIONS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | disclosed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | disclosed |
| US-11324776-B2 | Maillard reaction products as inhibitors of aggregatibacter actinomycetemcomitans | NATIONAL GUARD HEALTH AFFAIRS (SA) | 2022-05-10 | — | — | US | disclosed |
| US-20210283154-A1 | MAILLARD REACTION PRODUCTS AS INHIBITORS OF AGGREGATIBACTER ACTINOMYCETEMCOMITANS | NATIONAL GUARD HEALTH AFFAIRS (SA) | 2021-09-16 | — | — | US | disclosed |
| US-20010024798-A1 | Biomimetic combinatorial synthesis | SHAIR MATTHEW D (US) | 2001-09-27 | — | — | US | disclosed |
| WO-1999064379-A2 | BIOMIMETIC COMBINATORIAL SYNTHESIS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1999-12-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230089351-A1 | METHODS RELATED TO BIOACTIVE AGENTS THAT CONVERT FROM ANIONS TO MOLECULES | FABP2, FABP4, GUSB | ERN1 3906/4885GABRA3 4037/4885GABRA2 4115/4885 |
| US-20260002924-A1 | METHOD FOR SELECTING ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS FROM MIXTURE OF ESTER FUNCTIONAL GROUP-CONTAINING POLYMERS AND OTHER TYPES OF POLYMERS | FGB, NR4A1, CYP2E1 | ERN1 622/4885GABRA3 2027/4885GABRA2 1712/4885 |
| US-11324776-B2 | Maillard reaction products as inhibitors of aggregatibacter actinomycetemcomitans | AGER, AAAS, MGAM | ERN1 1913/4885GABRA3 3513/4885GABRA2 3107/4885 |
| US-20210283154-A1 | MAILLARD REACTION PRODUCTS AS INHIBITORS OF AGGREGATIBACTER ACTINOMYCETEMCOMITANS | AGER, AAAS, MGAM | ERN1 1913/4885GABRA3 3513/4885GABRA2 3107/4885 |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | ERN1 2621/4885GABRA3 3245/4885GABRA2 3499/4885 |
| US-20010024798-A1 | Biomimetic combinatorial synthesis | COASY, BBOX1, CYP4B1 | ERN1 1036/4885GABRA3 1680/4885GABRA2 1651/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.